Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
The Trailblazer Award is for New and Early Stage Investigators to conduct research at the intersection of engineering, physical sciences, and life or biomedical sciences. Projects should be exploratory, developmental, proof of concept, or high risk-high impact, and can be focused on technology design, discovery, or hypothesis testing. No preliminary data is needed and is not encouraged, but minimal data is allowed if available. If included, preliminary data must be independently created by t…
This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators (https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs that integrate engineering and the physical sciences with the life and/or biomedical sciences. A Trailblazer projec…
Source
Grant ID
PAR-24-022
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Program
SBIR
Key Dates
Opportunity Released
November 18, 2022
Open for Submission
November 18, 2022
Submission Deadline
January 7, 2026
Application Window Closes
January 7, 2026
Awards & Funding
Award Ceiling
$400,000
Funding Amount
~$400,000
Similar opportunities
- Notice of Intent to Publish a Funding Opportunity Announcement for Trailblazer Award for New and Early-Stage Investigators (R21 Clinical Trial Optional)
- Trailblazer Award for New and Early Stage Investigators
- NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- NIH Midcareer Investigator Award in Patient-Oriented Research (K24)